Addition of panitumumab to irinotecan: Results of PICCOLO, a randomized controlled trial in advanced colorectal cancer (aCRC).

• DOI: 10.1200/jco.2011.29.15_suppl.3523
• Publication Date: 2017-02-23T18:58:03Z
• Authors: M. T. Seymour; S. R. Brown; S. Richman; G. W. Middleton; T. Maughan; C. Olivier; S. J. Gwyther; J. Wadsley; I. Chau; T. Hickish; L. K. Dawson; S. Falk; A. O'Callaghan; K. Benstead; N. Wadd; A. Oliver; P. Chambers; H. Marshall; V. Napp; P. Quirke
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

3523 Background: Phase III trials show inconsistent effects when anti-EGFR drugs are added to cytotoxic therapy in aCRC. Benefits, when present, are confined to patients (pts) determined retrospect...